Trials / Completed
CompletedNCT01686581
An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine
A 24-month, Prospective, Non-interventional Study to Describe the Long Term, Real-Life Use of BOTOX® for the Symptomatic Treatment of Adults With Chronic Migraine, Measuring Healthcare Resource Utilization, and Patient Reported Outcomes Observed in Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 641 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to describe the long term use of Onabotulinumtoxin A (BOTOX®) as prescribed by the physician for headache prophylaxis in adults with chronic migraine. All treatment decisions lie with the physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | botulinum toxin Type A | Botulinum toxin Type A (BOTOX®) administered according to physician prescription. |
Timeline
- Start date
- 2012-07-23
- Primary completion
- 2016-10-12
- Completion
- 2016-10-12
- First posted
- 2012-09-18
- Last updated
- 2018-11-09
- Results posted
- 2018-11-09
Locations
77 sites across 7 countries: Germany, Italy, Norway, Russia, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01686581. Inclusion in this directory is not an endorsement.